Rebirth of the God-level Xueba

Pharmaceutical companies are among the most paying companies in the world. Bayi??Chinese W?W?W. 81 ZW. COM

Counting from top to bottom, from Pfizer Pharmaceuticals to Mozambique Beira Pharmaceutical Factory, one counts one by one. The expenditures on publicity and marketing, government public relations, and legal security are all in the forefront of various industries.

To put it simply, the more lucrative a company with a bad reputation, the more it needs to spend a lot of extra money to maintain its already collapsed image and protect the fragile ecological chain, such as arms dealers, energy companies or pharmaceutical companies.

On the other hand, the larger the scale of the company, the greater the degree of cross-border and cross-regional, and the more resources need to be invested in it.

Why is Coca-Cola willing to pay tens of thousands of dollars to Yang Rui for an investment that is not in their plan? Because in their marketing plan, it is too common to spend tens of thousands of dollars to hold a meeting and do a project. Even the Coca-Cola Company in China is willing to spend a lot of money when it finds a suitable project. cash.

In some cases, such multinationals will pay tens of thousands of dollars to a little-known academic in exchange for his "speaking of justice", or simply a speech to a crowd that doesn't care. Round-trip first-class air tickets and hotel expenses, plus lecture expenses, are staggering enough.

Pharmaceutical companies are even more aggressive.

When a company spends tens of millions of dollars on various lawsuits every year on average, their generosity in maintaining relationships is more than the annual output value of an ordinary factory.

Pharmaceutical companies sometimes pocket hundreds of millions of dollars for a lobbying effort involving new drugs.

Astra is also one of the few original drug companies in the world. It pays countless taxes to the Swedish government every year, and the annual turnover of selling drugs is tens of billions of dollars.

For pharmaceutical companies at this level, the first thing they need to care about is the research and development of drugs and the launch of new drugs.

In fact, compared with small pharmaceutical companies, large pharmaceutical companies may not necessarily have stronger research and development capabilities. Their most accustomed method is still to purchase the patents of small pharmaceutical companies, and use their strong marketing capabilities and government relations to promote drugs. go out.

However, drug patents are only a part of drug research and development.

At the level of Astra, they not only have to care about what new drugs are out, but also what new drugs we can do now.

What new drugs can be made depends on the development and initiative of basic medicine.

For example, g protein-coupled receptors,

It will be the source of new drugs for a long time in the future. At one time, 50% of new drugs were focused on g-protein coupled receptors.

Astra was naturally unwilling to be left behind, and they grabbed the olive branch that Yang Rui handed over.

A company like a large pharmaceutical company is not afraid of your conditions at all, especially a pharmaceutical company in Sweden.

Yang Rui is not the first biologist interested in the Nobel Prize, nor will he be the last.

After the simple visit to the pharmaceutical factory that day, without greetings from Yang Rui or Zhou Yingyao, the Astra official who was in charge of the itinerary and introduction came over and said, "Mr. Yang Rui, I heard that your Chinese embassy is going to hold a dinner. I've signed up."

"Oh, thank you for your participation." Yang Rui showed considerable enthusiasm.

"Let me introduce myself again, Pulitzer. I am from Stockholm. When I was a child, my favorite festival every year was the Nobel Prize ceremony." Pulitzer smiled and said, "Stockholm at that time was One of the liveliest places where we drink, laugh and watch real scientists win awards together."

Yang Rui nodded slightly.

"There is a saying that even the most lively Swedes are not as outgoing as the most shy Americans, except after drinking." Pulitzer raised the wine glass in his hand and said: "Mr. Yang Rui, Astra believes that your research on g protein-coupled receptors and pcR has admirable originality and admirable influence, and you deserve the Nobel Prize."

"Does Astra think so?"

"certainly."

"Thank you very much for your appreciation." Yang Rui couldn't help but look up. This is the meaning of his coming to Sweden. He has to tell people that someone here is qualified to win the Nobel Prize, and this person is willing to win the Nobel Prize.

However, Astra was originally the easiest Swedish company to conquer. Their relationship with Zeneca and their lack of integrity as a pharmaceutical company all determined that they were more willing to support Yang Rui. But, from a stepping stone perspective, Astra makes a lot of sense.

Yang Rui also said affectionately: "The attitude of Astra is very important to me, Mr. Pulitzer, you are the first company I contacted in Sweden, and you are also the first company to give me full support. grateful."

Pulitzer smiled very Swedish, restrained himself very quickly, and said, "Mr. Yang Rui, I want to make one thing clear. It can't be called the full support of Astra now. Of course, we support you very much... ..."

"Under what conditions will you fully support it?" Faced with such a multinational company, even if it is a Swedish multinational company, Yang Rui does not have to maintain the so-called celebrity demeanor.

A commercial company is a company that pays attention to transactions, and Yang Rui is also a person with capital.

Pulitzer looked at Yang Rui quite unexpectedly, and said: "Your actions remind me of Americans, oh no, it should be more like British."

"Oh?"

"The British always discuss some very important issues in a flat tone."

"That's why oo7 in the UK is very famous." Yang Rui smiled, and said again: "I think the Swedes are always very calm."

"It's better to say indifference." Pulitzer changed the subject and said, "Mr. Yang Rui, if Astra fully supports you, what kind of return can you provide?"

"I can teach your researchers for a month and answer their questions." Yang Rui said.

Pulitzer froze for a moment, couldn't help laughing, and said, "Mr. Yang Rui, you are a person who is good at telling jokes."

"It's not a joke, Mr. Pulitzer."

Pulitzer put on a straight face and said: "Mr. Yang Rui, I would rather think it is a joke. Astra is a large pharmaceutical company with many years of tradition and confidence. We are willing to accept information from the outside world and cooperate with other National researchers talk to each other, but..."

"It took me only two months to make deferiprone." Yang Rui didn't let him finish, and interrupted: "And I made 7 active substances. Now it seems that the third phase of clinical trials is also going well. , there is no problem in the fourth phase of clinical trials..."

Pulitzer was suddenly at a loss for words. Making original new drugs is a big deal for any big company. Although Astra is a big company with tens of billions of dollars in marketing, the original new drugs they can pass every year-in fact, no big company can do it. There are original new drugs every year, and cruelty is the norm when it comes to drug development.

"Think about it." Yang Rui's voice was full of temptation, and said: "I am the researcher who knows the most about g protein-coupled receptors in the world. Although I am a little embarrassed to boast like this, but you think my positioning is appropriate ?"

"I think it's very appropriate." Pulitzer said this sentence firmly, and the thought in his mind was born in an instant.

The reason why the research on g-protein coupled receptors is called Wang Qi is because its seven transmembrane mechanism is too abnormal, it affects almost every aspect of the human body, from the sense of smell to life support...

In other words, through g protein-coupled receptors, it can also affect all aspects of the human body, and the resulting targets are simply countless.

As for Yang Rui, he is the man holding the Wang Banner.

Although the news that Yang Rui has completed the second stage of G protein-coupled receptors has not yet spread, and Pulitzer does not know about it, but his progress in the first stage alone has not yet been replicated by anyone.

In other words, Yang Rui is the well-deserved number one in terms of g-protein coupled receptors.

What's even more rare is that he is not only a biologist who only understands basic research, he also presided over the development of a new drug.

Such an experience made Pulitzer envious.

"Full support is a big topic." Pulitzer's expression became serious, and he said, "I don't have the right to make a decision, but I can report to netbsp; Sweden is the country that advocates flat management the most, and many people are qualified to report to the top.

Yang Rui nodded, laughed again, and said, "Don't be too nervous, maybe you can arrange some time for me to have some in-depth conversations with your researchers, such as in the form of lectures?"

"Would you like that?"

"certainly."

"Great, thank you very much." Pulitzer immediately agreed, "I'll make corresponding arrangements right away... Oh, do you want to name the lecture?"

"How about the experience class of g-protein coupled receptors." In Yang Rui's mind, the image of a salesperson who gave out trial kits emerged in Yang Rui's mind.